Niue Health Report: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Niue Health Report.

Press releases published on August 10, 2026

14 hours ago

Axsome Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire

14 hours ago

Instinct Bio Announces Strategic Collaboration with PT PARVA CANDELA to Develop Cosmetics Business in Indonesia

Indeterminate GlobeNewswire

14 hours ago

Curium acquires Abscint SA, expanding PET radiodiagnostic pipeline in oncology

Indeterminate GlobeNewswire

14 hours ago

Grifols Announces Last Patient Last Visit in SPARTA, its Phase 3 Outcomes Study of Prolastin®-C in Patients With Emphysema Due to Alpha-1 Antitrypsin Deficiency

Indeterminate GlobeNewswire

14 hours ago

Tenax Therapeutics Announces Topline Results from Phase 3 LEVEL Clinical Trial of TNX-103 in Patients with PH-HFpEF

Indeterminate GlobeNewswire

15 hours ago

Veru Reports Fiscal 2026 Third Quarter Financial Results and Phase 2b PLATEAU Clinical Trial Progress

Indeterminate GlobeNewswire

15 hours ago

Greenwich LifeSciences Extends Lock-up of Directors and Officers to January 31, 2027

Indeterminate GlobeNewswire

15 hours ago

New Peer-Reviewed Research Reinforces What the Data Has Shown for Years: Vaping Has Saved Canadian Lives

Indeterminate GlobeNewswire

15 hours ago

Hopstem Announces the first Closing of Series C Financing to Accelerate the Development of iPSC-Derived Forebrain Neural Cell Therapy

Indeterminate GlobeNewswire

16 hours ago

Internationally Recognized Johns Hopkins Oncologist Dr. Stephen J. Noga Joins Immunocine as Chief Medical Officer

Indeterminate GlobeNewswire

17 hours ago

Reacta Healthcare Announces the Appointment of Iedena Lima as Head of Research and Development

Indeterminate GlobeNewswire

18 hours ago

Oculis Signs Asset Purchase Agreement with Accure Therapeutics for Lead Candidate, Privosegtor, Fortifying Oculis’ Position as an Emerging Leading Neuro-Ophthalmology Company

Indeterminate GlobeNewswire

18 hours ago

Novonesis to acquire remaining share of MicroBioGen to strengthen yeast capabilities

Indeterminate GlobeNewswire

Aug. 10, 2026

Nicox Announces NCX 470 NDA Submission in China by Partner Ocumension

Indeterminate GlobeNewswire

Aug. 10, 2026

Nicox annonce la soumission d’une NDA pour NCX 470 en Chine par son partenaire Ocumension

Indeterminate GlobeNewswire